Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transgenic animals as models for human disease

J Wagner1, F Thiele, D Ganten

  • 1German Institute for High Blood Pressure Research, Berlin.

Clinical and Experimental Hypertension (New York, N.Y. : 1993)
|May 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-throughput scanning of the rat genome using interspersed repetitive sequence-PCR markers.

Genomics·2000
Same author

Reduced cardiac hypertrophy and altered blood pressure control in transgenic rats with the human tissue kallikrein gene.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2000
Same author

Angiotensin peptides acting at rostral ventrolateral medulla contribute to hypertension of TGR(mREN2)27 rats.

Physiological genomics·2000
Same author

Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects.

Kidney international·2000
Same author

Gluco- and mineralocorticoid receptor-mediated regulation of neurotrophic factor gene expression in the dorsal hippocampus and the neocortex of the rat.

The European journal of neuroscience·2000
Same author

Effect of bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage.

Hypertension (Dallas, Tex. : 1979)·2000
Same journal

Adiponectin improves the aortic dissection by inhibiting inflammatory cell infiltration and macrophage pyroptosis.

Clinical and experimental hypertension (New York, N.Y. : 1993)·2026
Same journal

Electroacupuncture for essential hypertension: Mechanistic insights, current clinical evidence, and translational challenges.

Clinical and experimental hypertension (New York, N.Y. : 1993)·2026
Same journal

Association of intracranial atherosclerotic stenosis with 1-year cognitive impairment after acute ischemic stroke or transient ischemic attack: a nationwide prospective cohort study.

Clinical and experimental hypertension (New York, N.Y. : 1993)·2026
Same journal

Frailty as a mediator of the association between hyperuricemia and stroke risk: A prospective cohort study.

Clinical and experimental hypertension (New York, N.Y. : 1993)·2026
Same journal

Synergistic impact of nondipper heart rate and blood pressure on left ventricular hypertrophy in essential hypertension.

Clinical and experimental hypertension (New York, N.Y. : 1993)·2026
Same journal

From clinic to home monitoring: Diagnostic strategies and evidence landscape of white-coat uncontrolled hypertension.

Clinical and experimental hypertension (New York, N.Y. : 1993)·2026
See all related articles

Transgenic technology, using genetically modified animals, advances biomedical research by revealing gene functions in diseases like cancer and cardiovascular conditions. This powerful tool aids in understanding disease origins and developing future therapies.

Area of Science:

  • Biomedical Research
  • Genetics
  • Animal Models

Background:

  • Transgenic technology, established in 1981, has revolutionized biomedical research.
  • It involves introducing foreign DNA into animal genomes, impacting diverse fields like oncology, immunology, and cardiovascular medicine.

Purpose of the Study:

  • To investigate the role of specific genes in disease initiation and progression.
  • To leverage transgenic animals for studying human gene functions and disease pathophysiology.

Main Methods:

  • Microinjection of foreign DNA into fertilized oocytes.
  • Generation of genetically modified animals with germline integration and expression of foreign genes.

Main Results:

  • Transgenic animals have been instrumental in studying tumor development, immune regulation, cardiovascular development, and atherosclerosis.

Related Experiment Videos

  • These studies provide insights into the genetic basis of diseases and cellular pathology.

    • Conclusions:

    • Transgenic technology offers a vital link between molecular biology and whole animal physiology.
    • Future applications include developing novel diagnostic tools and therapeutic strategies, such as gene therapy.